Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2011

01-04-2011 | Original Article

Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time

Authors: Charlotte Dawson, Elaine Murphy, Charlé Maritz, Heidi Chan, Charlotte Ellerton, R. H. S. Carpenter, Robin H. Lachmann

Published in: Journal of Inherited Metabolic Disease | Issue 2/2011

Login to get access

Abstract

There is no evidence that high phenylalanine (Phe) levels have irreversible effects on the adult brain. Many adults with phenylketonuria (PKU) no longer follow a protein-restricted diet. Neuropsychological studies have shown that reaction time in adults with PKU is slower than controls. There are no data to show that this is directly related to Phe levels. Another way to assess reaction time is to measure saccadic latency. We have used a portable, head-mounted saccadometer to measure latency in the outpatient setting. Patients with PKU were split into three groups: off-diet (Phe>1,200 μmol/l), on-diet (Phe <800 μmol/l) and maternal diet (Phe 100–400 μmol/l ). Reciprocal median latency (RML) was compared between groups. Latency was significantly slower in patients who were off-diet than in patients on-diet, on a maternal diet or in normal controls. Reaction times in both diet-treated groups were not significantly different from normal controls. In 16 women planning pregnancy we obtained values before and after they commenced the maternal diet. Stricter control of Phe levels resulted in a significant improvement in reaction times. We conclude that saccadometry is useful in monitoring PKU patients. Adult patients with PKU not on a protein-restricted diet have significantly slower reaction times than controls. In addition, off-diet patients have significantly slower reaction times than on-diet. Paired data show that effects of Phe levels on reaction time are reversible.
Literature
go back to reference Albrecht J, Garbade SF, Burgard P (2009) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414–421PubMedCrossRef Albrecht J, Garbade SF, Burgard P (2009) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414–421PubMedCrossRef
go back to reference Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington's disease. Exp Brain Res 169:237–245PubMedCrossRef Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington's disease. Exp Brain Res 169:237–245PubMedCrossRef
go back to reference Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–120PubMedCrossRef Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–120PubMedCrossRef
go back to reference Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–79PubMedCrossRef Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–79PubMedCrossRef
go back to reference Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62PubMedCrossRef Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62PubMedCrossRef
go back to reference Christ SE, Huijbregts SC, de Sonneville LM, White DA (2010) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99:S22–S32PubMedCrossRef Christ SE, Huijbregts SC, de Sonneville LM, White DA (2010) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99:S22–S32PubMedCrossRef
go back to reference Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255PubMedCrossRef Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255PubMedCrossRef
go back to reference de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–89PubMedCrossRef de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–89PubMedCrossRef
go back to reference Gassió R, Campistol J, Vilaseca MA, Lambruschini N, Cambra FJ, Fusté E (2003) Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 92:1474–1478PubMedCrossRef Gassió R, Campistol J, Vilaseca MA, Lambruschini N, Cambra FJ, Fusté E (2003) Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 92:1474–1478PubMedCrossRef
go back to reference Gentile JK, Ten Hoedt AE, Bosch AM (2010) Psychosocial aspects of PKU: hidden disabilities—a review. Mol Genet Metab 99(Suppl 1):S64–67PubMedCrossRef Gentile JK, Ten Hoedt AE, Bosch AM (2010) Psychosocial aspects of PKU: hidden disabilities—a review. Mol Genet Metab 99(Suppl 1):S64–67PubMedCrossRef
go back to reference Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123PubMedCrossRef Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123PubMedCrossRef
go back to reference Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700–705PubMed Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700–705PubMed
go back to reference Ober JK, Przedpelska-Ober E, Gryncewicz W et al (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J (ed) Modelling and measurement in medicine. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN, Warsaw, pp 187–198 Ober JK, Przedpelska-Ober E, Gryncewicz W et al (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J (ed) Modelling and measurement in medicine. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN, Warsaw, pp 187–198
go back to reference Pearson BC, Armitage KR, Horner CWM, Carpenter RHS (2007) Saccadometry: the possible application of latency distribution measurement for monitoring concussion. Br J Sports Med 41:610–612PubMedCrossRef Pearson BC, Armitage KR, Horner CWM, Carpenter RHS (2007) Saccadometry: the possible application of latency distribution measurement for monitoring concussion. Br J Sports Med 41:610–612PubMedCrossRef
go back to reference Pietz J, Kreis R, Schmidt H, Meyding-Lamadé UK, Rupp A, Boesch C (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413–420PubMed Pietz J, Kreis R, Schmidt H, Meyding-Lamadé UK, Rupp A, Boesch C (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413–420PubMed
go back to reference Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169–1178PubMedCrossRef Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169–1178PubMedCrossRef
go back to reference Donlon J, Levy H, Scriver CR (2008) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Valle D, Beaudet AL, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, online. McGraw-Hill, New York Donlon J, Levy H, Scriver CR (2008) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Valle D, Beaudet AL, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, online. McGraw-Hill, New York
go back to reference van Spronsen FJ, Hoeksma M, Reijngoud D (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef van Spronsen FJ, Hoeksma M, Reijngoud D (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef
go back to reference Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145–1156PubMedCrossRef Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145–1156PubMedCrossRef
go back to reference Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, Francis DE, Shortland GJ, Schmidt M, Vail A (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, Francis DE, Shortland GJ, Schmidt M, Vail A (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef
Metadata
Title
Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time
Authors
Charlotte Dawson
Elaine Murphy
Charlé Maritz
Heidi Chan
Charlotte Ellerton
R. H. S. Carpenter
Robin H. Lachmann
Publication date
01-04-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9276-2

Other articles of this Issue 2/2011

Journal of Inherited Metabolic Disease 2/2011 Go to the issue